2026 ICD-10-CM Diagnosis Code D68.59Other primary thrombophilia
ICD-10-CM Codes›D50–D89›D65-D69›D68
- Billable — Valid for Submission
- CC — Complication or Comorbidity
- Chronic Condition
D68.59 is a billable ICD-10-CM diagnosis code for other primary thrombophilia. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 814 through 816. As a secondary diagnosis, it counts as a complication or comorbidity (CC) and moves an inpatient stay to a higher severity level within its MS-DRG family. It does not count, however, when the principal diagnosis is one of 42 closely related codes. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Coagulation and hemorrhagic disorders.
D68.59 no longer risk-adjusts for Medicare Advantage: it mapped to HCC 48 under the retired CMS-HCC V24 model through payment year 2025 but maps to no category in the live V28 model. It still risk-adjusts in the PACE (CMS-HCC V22) category 48, ESRD (V21) category 48, and ESRD (V24) category 48 for payment year 2026.
Code Identity
Code Classification
Medicare Risk Adjustment (HCC)Billing
D68.59 no longer risk-adjusts for Medicare Advantage: it maps to no payment category in the live CMS-HCC V28 model, although it still risk-adjusts in the other CMS models shown below.
Source: CMS Payment Year 2026 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Acquired antithrombin III deficiency
- Acquired heparin cofactor II deficiency
- Acquired protein C deficiency
- Acquired protein S deficiency
- Antithrombin III deficiency
- Cerebral ischemic stroke due to hypercoagulable state
- Fibrinogen in blood above reference range
- Heparin cofactor II deficiency
- Hereditary antithrombin III deficiency
- Hereditary elevated factor VIII
- Hereditary elevated factor XI
- Hereditary heparin cofactor II deficiency
- Hereditary hyperfibrinogenemia
- Hereditary protein C deficiency
- Hereditary protein S deficiency
- Hereditary thrombophilia
- Hereditary thrombophilia due to congenital histidine-rich glycoprotein deficiency
- Heterozygous protein C deficiency
- Heterozygous protein S deficiency
- Homozygous protein C deficiency
- Homozygous protein S deficiency
- Hypercoagulability state
- Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency
- Hyperfibrinogenemia
- Protein C deficiency disease
- Protein S deficiency disease
- Thrombophilia
- Thrombotic tendency observations
- Upper gastrointestinal hemorrhage associated with hypercoagulability state
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- Antithrombin III deficiency
- Hypercoagulable state NOS
- Primary hypercoagulable state NEC
- Primary thrombophilia NEC
- Protein C deficiency
- Protein S deficiency
- Thrombophilia NOS
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
Hypercoagulable (state) D68.59
primary NEC D68.59
protein C deficiency D68.59
protein S deficiency D68.59
Hypercoagulation (state) D68.59
Thrombophilia D68.59
primary NEC D68.59
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Thrombophilia
a disorder of hemostasis in which there is a tendency for the occurrence of thrombosis.Antithrombin III Deficiency
an absence or reduced level of antithrombin iii leading to an increased risk for thrombosis.Antithrombin III Deficiency
a rare disorder characterized by the presence of low levels of antithrombin iii which prohibits the formation of blood clots. it may be inherited, usually in an autosomal dominant pattern, or acquired. it may lead to venous thrombosis and pulmonary embolism.
Patient EducationClinical
Bleeding Disorders
Normally, if you get hurt, your body forms a blood clot to stop the bleeding. For blood to clot, your body needs cells called platelets and proteins known as clotting factors. If you have a bleeding disorder, you either do not have enough platelets or clotting factors or they don't work the way they should.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert D68.59 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About D68.59Overview
What is the ICD-10 code for other primary thrombophilia?
The ICD-10-CM code for other primary thrombophilia is D68.59 (sometimes written as D6859). It is billable on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
Is D68.59 (Primary thrombophilia) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report other primary thrombophilia on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does D68.59 group to?
When other primary thrombophilia is the principal diagnosis on an inpatient stay, it groups to MS-DRG 814, 815, 816, with relative weights from 0.6320 to 2.1267 depending on complications. Higher weights mean higher Medicare reimbursement.
Is D68.59 a CC or MCC?
CMS lists D68.59 as a CC (complication or comorbidity) for FY 2026. Reported as a secondary diagnosis, it moves the inpatient stay to a higher-weighted DRG within its severity family. It does not count when the principal diagnosis is one of the 42 closely related codes in its exclusion list.
What is the ICD-9 equivalent of D68.59?
Under the General Equivalence Mappings, other primary thrombophilia converts to ICD-9-CM 289.81 (prim hypercoagulable st). The mapping is approximate, so confirm the match fits the documentation.
Does D68.59 risk-adjust for Medicare Advantage payment?
Not for Medicare Advantage. D68.59 mapped to HCC 48 in the retired CMS-HCC V24 model, which last determined payment in 2025, but it maps to no category in the live V28 model; see all codes that no longer risk-adjust. It still risk-adjusts in the PACE (CMS-HCC V22) category 48 (Coagulation Defects and Other Specified Hematological Disorders), ESRD (V21) category 48 (Coagulation Defects and Other Specified Hematological Disorders), and ESRD (V24) category 48 (Coagulation Defects and Other Specified Hematological Disorders).